Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
NVUS

Novus Therapeutics

$1.68

(0.00%)

16:10
06/07/19
06/07
16:10
06/07/19
16:10
Syndicate
Breaking Syndicate news story on Novus Therapeutics »

Novus Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVUS

Novus Therapeutics

$4.28

(0.00%)

08:15
04/22/19
04/22
08:15
04/22/19
08:15
Hot Stocks
Novus Therapeutics says OP0201 was 'safe and well-tolerated' in clinical trials »

Novus Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a quarter ago
NVUS

Novus Therapeutics

$4.24

(0.00%)

08:06
02/19/19
02/19
08:06
02/19/19
08:06
Hot Stocks
Novus Therapeutics doses first patients in OP0201 Phase 2a trial »

Novus Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVUS

Novus Therapeutics

$4.58

0.18 (4.09%)

08:05
02/11/19
02/11
08:05
02/11/19
08:05
Hot Stocks
Novus Therapeutics doses first subjects in OP0201 Phase 1 pharmacodynamics study »

Novus Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVUS

Novus Therapeutics

$2.65

-0.05 (-1.85%)

08:12
01/30/19
01/30
08:12
01/30/19
08:12
Hot Stocks
Novus Therapeutics advances OP0201 development program across several trials »

Novus Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVUS

Novus Therapeutics

$2.07

0.05 (2.48%)

08:11
01/08/19
01/08
08:11
01/08/19
08:11
Hot Stocks
Novus Therapeutics doses first patient in phase 1 clinical trial of OP0201 »

Novus Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVUS

Novus Therapeutics

$3.63

(0.00%)

11:52
11/27/18
11/27
11:52
11/27/18
11:52
Hot Stocks
Novus Therapeutics announces dosing of first subjects in Phase 1 study of OP0201 »

Novus Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

NVUS

Novus Therapeutics

$4.55

0.04 (0.89%)

09:24
09/11/18
09/11
09:24
09/11/18
09:24
Initiation
Novus Therapeutics initiated at Ladenburg »

Novus Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVUS

Novus Therapeutics

$3.84

-0.34 (-8.13%)

09:29
09/07/18
09/07
09:29
09/07/18
09:29
Syndicate
Novus Therapeutics to postpone offering of common stock »

Novus Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Sep

NVUS

Novus Therapeutics

$4.50

-0.5 (-10.00%)

16:06
09/04/18
09/04
16:06
09/04/18
16:06
Syndicate
Novus Therapeutics files to sell 6M shares of common stock »

Piper Jaffray & Co.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.